Abbott (ABT) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott (ABT) ended the recent trading session at $109.95, demonstrating a +1.78% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 1.01%. Meanwhile, the Dow gained 0.83%, and the Nasdaq, a tech-heavy index, added 1.22%. Heading into today, shares of the maker of infant formula, medical devices and drugs had lost 4.13% over the past month, outpacing the Medical sector's loss of 5.53% and lagging the S&P 500's loss of 2.86%. Investors will be eagerly watching for the performance of Abbott in its upcoming earnings disclosure. The company's upcoming EPS is projected at $1.15, signifying a 5.50% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $11.03 billion, reflecting a 6.53% rise from the equivalent quarter last year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $5.68 per share and a revenue of $47.74 billion, signif
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Diabetes And Cardiology Updates Test Growth Story For Investors [Yahoo! Finance]Yahoo! Finance
- This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India [Yahoo! Finance]Yahoo! Finance
- Invesco Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- How The Story On Abbott Laboratories (ABT) Is Shifting As Analysts Rework Targets And Risks [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website